Related content

Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: An Acta Oncologica expert report

By Nygren Peter   Sørbye Halfdan   Österlund Pia   Pfeiffer Per  

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 203-217

Informa Healthcare

Access to resources Recommend Favorite

Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer

By Rha Sun  

Breast Cancer Research and Treatment, Vol. 90, Iss. 3, 2005-04 ,pp. : 215-221

Springer Publishing Company

Access to resources Recommend Favorite

Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancer

By Larsen Finn Ole   Pfeiffer Per   Nielsen Dorte   Skougaard Kristin   Qvortrup Camilla   Vistisen Kirsten   Fromm Anne-Lene   Jøørgensen Trine L.   Bjerregaard Jon K.   Hoegdall Estrid   Jensen Benny V.  

Acta Oncologica, Vol. 50, Iss. 4, 2011-05 ,pp. : 574-577

Informa Healthcare

Access to resources Recommend Favorite

Behavioral disorders secondary to profound hypomagnesemia in a patient given cetuximab for metastatic colorectal cancer hypomagnesemia due to cetuximab treatment

By Perrin Christophe   Fabre Cédric   Raoul Jean-Luc   Boucher Eveline  

Acta Oncologica, Vol. 45, Iss. 8, 2006-12 ,pp. : 1135-1136

Informa Healthcare

Access to resources Recommend Favorite

Cetuximab in the treatment of colorectal cancer

By Ciardiello Fortunato   De Vita Ferdinando   Orditura Michele   Comunale Daniela   Galizia Gennaro  

Future Oncology, Vol. 1, Iss. 2, 2005-04 ,pp. : 173-181

Future Medicine

Access to resources Recommend Favorite